dc.creatorBUCHPIGUEL, Carlos Alberto
dc.date.accessioned2012-03-26T18:53:02Z
dc.date.accessioned2018-07-04T14:17:18Z
dc.date.available2012-03-26T18:53:02Z
dc.date.available2018-07-04T14:17:18Z
dc.date.created2012-03-26T18:53:02Z
dc.date.issued2011
dc.identifierRevista Brasileira de Hematologia e Hemoterapia, v.33, n.2, p.140-147, 2011
dc.identifier1516-8484
dc.identifierhttp://producao.usp.br/handle/BDPI/10232
dc.identifier10.5581/1516-8484.20110035
dc.identifierhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842011000200013
dc.identifierhttp://www.scielo.br/pdf/rbhh/v33n2/v33n2a13.pdf
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1608042
dc.description.abstractLymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma.
dc.languageeng
dc.publisherAssociação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea
dc.relationRevista Brasileira de Hematologia e Hemoterapia
dc.rightsCopyright Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea
dc.rightsopenAccess
dc.subjectLymph Nodes - radionuclide imaging
dc.subjectLymphoma - radionuclide imaging
dc.subjectPositron-emission tomography
dc.subjectFluorodeoxyglucose F18 - diagnostic use
dc.subjectLymphoma, Hodgkin's disease
dc.subjectLymphoma, non-Hodgkin
dc.titleCurrent status of PET/CT in the diagnosis and follow up of lymphomas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución